SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-005571
Filing Date
2019-02-04
Accepted
2019-02-04 17:03:29
Documents
4
Period of Report
2019-02-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-3981_18k.htm 8-K 23356
2 EX-99.1 a19-3981_1ex99d1.htm EX-99.1 27502
3 GRAPHIC g39811mmi001.jpg GRAPHIC 4257
4 GRAPHIC g39811mmi002.jpg GRAPHIC 9682
  Complete submission text file 0001104659-19-005571.txt   71413
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38410 | Film No.: 19564780
SIC: 2834 Pharmaceutical Preparations